Abstract
The dynamics of microvesicle formation in arterial blood in generalized Schwartzman phenomenon was studied. Successive (with 24-h interval) intravenous injections of endotoxin to rabbits in a dose of 1 mg/kg and 3 mg/kg caused an increase in the content of microvesicles in the blood, some of them containing ecto-5′-nucleotidase. Biphasic changes in arterial blood clotting time and erythrocyte hemolysis were observed.
Similar content being viewed by others
References
L. V. Galembskaya, Vopr. Med. Khim., 44, No. 5, 501–505 (1998).
D. M. Zubairov, I. A. Andrushko, and L. D. Zubairova, Gematol. Transfuziol., 44, No. 5, 24–30 (1999).
D. M. Zubairov, I. A. Andrushko, L. D. Zubairova, and G. Yu. Svintenok, Tromboz, Gemostaz i Reologiya, No. 1, 27–31 (2003).
O. Aras, A. Shet, R. R. Bach, et al., Blood, 103, No. 12, 4545–4553 (2004).
J. P. Bronza, Semin. Thromb. Hemost., 16, No. 4, 326–332 (1990).
V. Bianchi and J. Spychala, J. Biol. Chem., 278, No. 47, 46,195–46,198 (2003).
J. M. Freyssinet, J. Thromb. Haemost., 1, No. 7, 1655–1662 (2003).
B. Hugel, G. Socie, T. Vu, et al., Blood, 93, No. 10, 3451–3456 (1999).
C. Kunzelmann-Marche, J. M. Freyssinet, and M. C. Martinez, J. Biol. Chem., 277, No. 22, 19,876–19,881 (2002).
S. M. Opal and C. T. Esmon, Crit. Care, 7, No. 1, 23–38 (2003).
B. Promdonkoy and D. J. Ellar, Biochem. J., 374, Pt. 1, 255–259 (2003).
J. Pugin, R. J. Ulevitch, and P. S. Tobias, J. Exp. Med., 178, No. 6, 2193–2200 (1993).
C. R. Raetz and C. Whitfield, Annu. Rev. Biochem., 71, 635–700 (2002).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 142, No. 11, pp. 517–520, November, 2006
Rights and permissions
About this article
Cite this article
Zubairova, L.D., Zubairov, D.M., Andrushko, I.A. et al. Cell microvesicles during experimental endotoxemia. Bull Exp Biol Med 142, 573–576 (2006). https://doi.org/10.1007/s10517-006-0421-8
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-006-0421-8